Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of H021 tablets in moderately to severely active ulcerative colitis
CTR20252378Phase 2Active
- Sponsor
- 江苏柯菲平医药股份有限公司
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of H021 in autoimmune colitis, sponsored by 江苏柯菲平医药股份有限公司. Started Jun 2025; status: active.
02
Drugs
H021
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on CTR20252378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252378.